Its not on the headline side effect list, but its common enough that patients flag it in forums and in clinical visits
But don't worry, the story of how GLP-1 was made into a viable drug is so interesting it's almost worthy of its own article
Patients with PWS are characterized by neonatal hypotonia, hyperphagia, developmental and cognitive delay, behavioral problems, dysmorphic features, and failure to thrive [3]
Retatrutide products are commonly supplied as lyophilized powder for laboratory research use
Nor does it factor in the time, often an hour attached to the drip, of the treatment
BPC-157 interacts with the nitric oxide (NO) system in a context-dependent manner, counteracting both NO-synthase inhibition and NO excess